Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
# Background The United Kingdom (UK) switched from using the 4-valent human papillomavirus (HPV) vaccine (Gardasil®) to the 9-valent vaccine (Gardasil 9®) in 2021. # Objective To estimate and compare the health and economic outcomes of 2 HPV vaccination programs in the UK targeting girls and boys a...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2022-06-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/001c.34721 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|